Whitehawk Therapeutics's total assets for Q4 2025 were $150.83M, a decrease of -9.69% from the previous quarter. WHWK total liabilities were $14.52M for the fiscal quarter, a 47.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.